Epirubicin: Biological Properties, Analytical Methods, and Drug Delivery Nanosystems.

Epirubicin (EPI) is a chemotherapeutic agent belonging to the anthracycline drug class indicated for treating several tumors. It acts by suppressing the DNA and RNA synthesis by intercalating between their base pair. However, several side effects are associated with this therapy, including cardiotoxicity and myelosuppression. Therefore, EPI delivery in nanosystems has been an interesting strategy to overcome these limitations and improve the safety and efficacy of EPI. Thus, analytical methods have been used to understand and characterize these nanosystems, including spectrophotometric, spectrofluorimetric, and chromatography. Spectrophotometric and spectrofluorimetric methods have been used to quantify EPI in less complex matrices due to their efficiency, low cost, and green chemistry character. By contrast, high-performance liquid chromatography is a suitable method for detecting EPI in more complex matrices (e.g., plasm and urine) owing to its high sensitivity. This review summarizes physicochemical and pharmacokinetic properties of EPI, its application in drug delivery nanosystems, and the analytical methods employed in its quantification in different matrices, including blood, plasm, urine, and drug delivery nanosystems.

Citation

Marcela Tavares Luiz, Jessyca Aparecida Paes Dutra, Leonardo Delello Di Filippo, Alberto Gomes Tavares Junior, Larissa Bueno Tofani, Juliana Maldonado Marchetti, Marlus Chorilli. Epirubicin: Biological Properties, Analytical Methods, and Drug Delivery Nanosystems. Critical reviews in analytical chemistry. 2023;53(5):1080-1093

Mesh Tags

Substances

PMID: 34818953

search → result